Pharma

PHARMA

Make your R&D more efficient
through In Silico trials and virtual patients.

More than 95% of molecules will never become a saleable drug either because of safety risks or lack of efficacy. The InSilicoTrials platform enables scientists to unleash the power of modeling and simulation in any stage of drug preclinical and clinical trials, to identify as early as possible the best candidates while assessing their efficacy and safety. 

Generate value across the whole R&D process

Main therapeutical areas

Cardiology

Infertility

Neurology

Oncology

Orthopedics

Nefrology

FEATURED PRODUCT

Drug Induced Cardiac Toxicity

Complement in vitro testing to assess drug-induced
proarrhythmic risks in drug candidates early screening.

Contact Us

Fill the form below and get more info
about our solutions